The test accuracy of antenatal ultrasound definitions of fetal macrosomia to predict birth injury: a systematic review by Robinson, Rebecca et al.
1 
 
The test accuracy of antenatal ultrasound definitions of fetal 1 
macrosomia to predict birth injury: a systematic review 2 
 3 
Rebecca Robinsona, Kate F Walkerb, Victoria A Whitec, George J Buggc, Kym IE Snelld, Nia W Jonesb 4 
 5 
aDerby Teaching Hospitals NHS Foundation Trust, Uttoxeter Road, Derby, DE22 3NE.  Rebecca 6 
Robinson, Specialty Trainee in Obstetrics and Gynaecology. 7 
bDivision of Child Health, Obstetrics and Gynaecology, School of Medicine, University of Nottingham.  8 
Kate F Walker, Clinical Assistant Professor in Obstetrics and Gynaecology.  Nia Jones, Associate 9 
Professor in Obstetrics and Gynaecology 10 
cQueen’s Medical Centre, Derby Road, Nottingham, NG7 2UH.  Victoria A White, Specialty Trainee in 11 
Obstetrics and Gynaecology.  George J Bugg, Consultant Obstetrician. 12 
dCentre for Prognosis Research, Research Institute for Primary Care & Health Sciences, Keele 13 
University, Staffordshire, ST5 5BG.  Kym Snell, Lecturer in Biostatistics. 14 
 15 
Correspondence to: Dr Kate Walker 16 
kate.walker@nottingham.ac.uk 17 
0115 823 1581 18 
 19 






To determine which ultrasound measurement for predicted fetal macrosomia most accurately 24 
predicts adverse delivery and neonatal outcomes. 25 
Study Design 26 
Four biomedical databases searched for studies published after 1966.  27 
Randomised trials or observational studies of women with singleton pregnancies, resulting in a term 28 
birth who have undergone an index test of interest measured and recorded as predicted fetal 29 
macrosomia ≥28 weeks. 30 
Adverse outcomes of interest included shoulder dystocia, brachial plexus injury (BPI) and Caesarean 31 
section. 32 
Results 33 
Twenty-five observational studies (13,285 participants) were included.  For BPI, the only significant 34 
positive association was found for Abdominal Circumference (AC) to Head Circumference (HC) 35 
difference > 50 mm (OR 7.2, 95% CI 1.8 to 29). Shoulder dystocia was significantly associated with 36 
abdominal diameter (AD) minus biparietal diameter (BPD) ≥ 2.6 cm (OR 4.2, 95% CI 2.3 to 7.5, PPV 37 
11%) and AC > 90th centile (OR 2.3, 95% CI 1.3 to 4.0, PPV 8.6%) and an estimated fetal weight (EFW) 38 
> 4000 g (OR 2.1 95%CI 1.0 to 4.1, PPV 7.2%).   39 
Conclusions 40 
Estimated fetal weight is the most widely used ultrasound marker to predict fetal macrosomia in the 41 
UK. This study suggests other markers have a higher positive predictive value for adverse outcomes 42 













Fetal macrosomia refers to a bigger than average baby in utero or at the time of birth.   Women with 54 
big babies tend to have longer labours and higher risk of operative delivery, perineal injury or shoulder 55 
dystocia.  Shoulder dystocia may cause birth injury, including brachial plexus injury (2-16%), bony 56 
fractures or birth asphyxia with risk of neurological damage or death [1].   57 
Macrosomia generally refers to a neonate with a birthweight > 4000 g regardless of gestational age.  58 
Predicted fetal macrosomia refers to a fetus with an ultrasonic estimated fetal weight (EFW) of > 4000 59 
g.  Many institutions use 4 kg as the definition but currently, an estimated weight of > 4.5 kg is more 60 
widely used as a threshold to define fetal macrosomia [2-4]. Babies that weigh ≥ 4.5 kg have an 61 
increased risk of adverse maternal and perinatal outcomes [5, 6]. Approximately 10% of all 62 
pregnancies result in fetal macrosomia but this estimate ranges from 3-15% [3, 7]. 63 
Antenatal detection of fetal macrosomia by ultrasound is notoriously poor.  Evidence has shown that 64 
the accuracy of ultrasound in estimating the weight of large babies has approximately 45-56% 65 
sensitivity for an EFW > 4000 g [8, 9] and 80% sensitivity for an abdominal circumference > 35cm [9].  66 
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A number of factors limit the accuracy of sonography which include: inaccuracy of the biometry 67 
measurements [10]; inexperienced operators; the equipment quality; oligohydramnios; maternal 68 
obesity and the inaccuracy of the formulae for EFW used [11]. 69 
Consensus has not yet been reached on the measurement definition of fetal macrosomia. A multitude 70 
of imaging measurement definitions to predict fetal macrosomia exist worldwide. Many studies have 71 
been published testing the diagnostic accuracy of antenatal prediction of fetal macrosomia in 72 
comparison to absolute birth weights. It is also known from a very large observational study what level 73 
of absolute birth weight is associated with complications [12]. These studies are only useful for 74 
retrospective analysis and do not help to guide clinical management. What we do not know is if any 75 
of these antenatal imaging predictions are (more or less) associated with adverse maternal and 76 
neonatal outcomes. 77 
The antenatal prediction of fetal macrosomia is particularly pertinent now.  The 2015 Supreme Court 78 
ruling, Montgomery v Lanarkshire has highlighted the importance of counselling women with 79 
suspected fetal macrosomia.  A recent Cochrane review (4 trials, 1190 women) found that induction 80 
of labour at 37-40 weeks for suspected fetal macrosomia reduced birthweight, fractures and shoulder 81 
dystocia [13].  Given that we have an effective intervention for suspected fetal macrosomia, trying to 82 
improve the accuracy of our prediction of fetal macrosomia has never been more important. 83 
We evaluated the association and test accuracy of ultrasound definitions of fetal macrosomia for the 84 
prediction of adverse maternal and neonatal outcomes. 85 
MATERIALS AND METHODS 86 
The study was prospectively registered (CRD42016046850).  87 
Study objective 88 
Which measurement definition of predicted fetal macrosomia most accurately predicts adverse 89 
maternal and neonatal outcomes? 90 
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Eligibility criteria 91 
Types of studies  92 
Randomised controlled trials or observational studies that allowed the generation of a 2x2 table to 93 
include true positives, false positives, false negative and true negatives. Any studies with ≤10 94 
participants were excluded due to the unreliability of a small sample [14]. Case control studies, when 95 
participants are selected for inclusion on the basis of the presence of their adverse outcome, are 96 
known to be prone to spectrum bias [15]. This fact was accounted for in the scoring system used in 97 
the quality assessment. 98 
Participants 99 
The population for inclusion were pregnant women with singleton pregnancies that resulted in a term 100 
birth (≥37 weeks). These pregnant women must have had an index test of interest measured and 101 
recorded as predicted fetal macrosomia ≥28 weeks. Studies including multiple pregnancies and 102 
premature deliveries were excluded.  103 
Index test 104 
All measurements and thresholds that have been described as methods to predict fetal macrosomia 105 
were included as index tests for the initial scoping searches.   Including all modalities (2D or 3D 106 
ultrasound (US) and magnetic resonance image (MRI).  All measurements and thresholds that have 107 
been described as methods to predict fetal macrosomia were included as index tests for the initial 108 
scoping searches, including all modalities (2D or 3D ultrasound (US) and magnetic resonance image 109 
(MRI).  Scoping searches were performed to determine whether there was available primary data for 110 
these measurement prediction parameters combined with the outcomes of interest. These initial 111 
searches revealed that for 3D US and MRI studies no clinical outcome data was recorded. Therefore, 112 
the index tests included in the review consisted of 2D ultrasound data only.  113 
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Ultrasound measurement defined as predicted fetal macrosomia included: EFW (>4k g, 4-4.5 kg, >4.5 114 
kg, >90th centile, >95th centile); abdominal circumference (AC) (>35 cm, >36 cm, >75th centile, >90th 115 
centile, > 95th centile); ratios of measurements and novel distances (e.g. abdominal 116 
diameter/biparietal diameter, femur length/abdominal circumference, cheek to cheek, humeral soft 117 
tissue thickness). These ultrasound markers were pre-defined. 118 
Primary analysis 119 
Search strategy 120 
The search was undertaken in May 2018 through the following electronic bibliographic databases 121 
(Medline, Embase, PubMed, and the Cochrane Library), sources of ‘grey’ literature (OpenGrey, Web 122 
of Science) and citation tracking on relevant studies. There was no language restriction.  The search 123 
strategy is shown in Appendix 1. 124 
Study selection 125 
The abstracts of potentially relevant studies were identified and screened by RCR, 10% were 126 
screened by VAW and no new papers were identified.  Relevant full-text studies were retrieved and 127 
assessed for eligibility by RCR and VAW.  Any disagreements were resolved by consultation with 128 
NWJ.   129 
Data extraction and quality assessment 130 
Data was extracted using a standardised form independently by VAW and RCR, from the included 131 
studies, for assessment of study quality and evidence synthesis. Each study had data extracted twice 132 
independently. The extracted information included the methodology and timing of the index tests 133 
as well as the outcomes, allowing the generation of 2 x 2 tables to calculate estimates of the 134 
association between the ultrasound marker and outcomes.  135 
The authors of included studies were contacted directly to request data if the manuscript did not 136 
provide enough information to populate the 2x2 tables.  137 
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The quality of included studies was assessed by a structured assessment completed independently by 138 
two reviewers (RCR and VAW). The STARD and QUADAS-2 published checklists are both validated 139 
methods for the study of methodological quality in the reporting of diagnostic test accuracy studies. 140 
[16, 17]. From within these validated tools, we selected the elements that best represented the 141 
methodical quality for systematic reviews that assess the association between prognostic tests and 142 
outcome. We used the same approach that has been used successfully by other similar, published 143 
systematic reviews and meta-analyses [18, 19].  144 
A study was rated as high quality (met at least four criteria), medium quality (three) and low (two or 145 
less). 146 
Data analysis 147 
We used aggregate data to quantitatively synthesise odds ratios (ORs) and 95% confidence intervals 148 
(95% CIs) for each index test-outcome pair. The results were pooled for each index test using a random 149 
effect meta-analysis to provide the summary estimate of prognostic association with outcome. If a 150 
strong and statistically significant prognostic association was identified between a test and an 151 
outcome measure, we calculated sensitivity, specificity and likelihood ratios from the 2x2 tables and 152 
then used a bivariate random-effects meta-analysis model to assess the predictive ability of the test.   153 
The prevalence was pooled for each outcome using a random-effects meta-analysis model and the 154 
exact binomial method. Sensitivity and specificity were pooled for each index test using a bivariate 155 
random-effects meta-analysis model. If the bivariate model could not be estimated or there were 156 
estimation concerns (e.g. for the correlation parameter), then univariate models were used to pool 157 
sensitivity and specificity separately, as recommended by Takwoingi et al [20]. The positive 158 
predictive value (PPV) for a new population was derived using the formula of Riley et al [21] which 159 
uses the summary sensitivity, specificity and prevalence (Table 2). The PPV is dependent on the 160 
prevalence used to calculate it and would change if the prevalence changed. 161 




Study selection 164 
Twenty-five observational studies (13,285 participants) were included (Figure 1).  Three of these were 165 
included after further data was provided by the authors.  Details of the included studies are shown in 166 
Table 1.  In total, 23 articles were excluded due to inadequate data for creation of the 2x2 tables or 167 
clarification of the population resulted in exclusion. 168 
Quality assessment 169 
Of the studies, 24 studies were classed as high (96%) and one was moderate quality (4%). All studies 170 
were observational studies.  Majority were cohort designs (84%) and retrospective (80%). The 171 
remaining studies were four prospective cohort studies and one prospective case control study. 172 
Accuracy of antenatal ultrasound definitions of fetal macrosomia to predict adverse outcomes 173 
 174 
Four studies [22-25] (31 - 362 women) reported brachial plexus injury as an outcome (Table 2).  For 175 
BPI, the only positive association was found for Abdominal Circumference (AC) to Head Circumference 176 
(HC) difference > 50 mm (OR 7.2, 95% CI 1.8 to 29) from a single study [31]. The PPV calculated for this 177 
test from that single study was 18%.    178 
Eighteen studies [10, 22-37] (11447 women test/outcome data sets) reported shoulder dystocia as an 179 
outcome. Three studies [26-28] reported on AC > 90th centile and shoulder dystocia. 180 
Three studies [23, 28, 29] reported on abdominal diameter minus biparietal diameter ≥ 2.6 cm.  Four 181 
studies reported on estimated fetal weight > 4000 g [11, 28, 35, 38]. The summary prevalence 182 
(calculated from these ten studies included in the meta-analysis) for shoulder dystocia was 4.9% (95% 183 
CI 2.1 to 11%) (Table 5). 184 
Meta-analysis revealed shoulder dystocia was associated with: abdominal diameter (AD) minus 185 
biparietal diameter (BPD) ≥ 2.6 cm (OR 4.2, 95% CI 2.3 to 7.5, PPV 11%) and AC > 90th centile (OR 2.3, 186 
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95% CI 1.3 to 4.0, PPV 8.6%) and an estimated fetal weight (EFW) > 4000 g (OR 2.1 95% CI 1.0 to 4.1, 187 
PPV 7.2%) (Table 3). PPVs were predicted for a new population with a prevalence of 4.9% for shoulder 188 
dystocia.  Full results are shown in Table 3. 189 
Fifteen studies [10, 24, 27, 32, 34-36, 38-45] (11630 women test/outcome data sets) reported 190 
caesarean section (CS) as an outcome.   The summary prevalence for CS in the studies was 36% (95% 191 
CI 23 to 51 %) (Table 5).  Five studies reported on CS and EFW > 4000 g [10, 32, 38, 43, 45].  For CS, 192 
the only positive association was found for EFW > 4000 g.  Meta-analysis demonstrated CS was 193 
associated with an EFW > 4000 g (OR 2.6, 95% CI 1.6 to 4.2, PPV 62%) (Tables 3).  Full results are shown 194 
in Table 4.  For those ultrasound measurements with a positive association between the measurement 195 
and an adverse outcome, the positive predictive values for each adverse outcome by ultrasound 196 
measurements are shown in Table 6. 197 
 198 
DISCUSSION 199 
Principal findings 200 
This study shows that the ultrasound marker of fetal macrosomia most associated with prediction of 201 
shoulder dystocia is a difference in the abdominal diameter to the biparietal diameter of ≥ 2.6 cm.  If 202 
this marker is positive then approximately 1 in 10 women will subsequently experience a shoulder 203 
dystocia.  The more widely used estimated fetal weight > 4 kg has more uncertainty as a predictor of 204 
subsequent shoulder dystocia with only 7 in 100 women subsequently experiencing a shoulder 205 
dystocia. 206 
The ultrasound marker of fetal macrosomia most associated with brachial plexus injury is an 207 
abdominal circumference to head circumference difference of > 50 mm. 208 
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The ultrasound marker of fetal macrosomia most associated with caesarean delivery is an estimated 209 
fetal weight > 4 kg.  If this marker is positive then approximately 1 in 2 women will subsequently have 210 
a caesarean delivery. 211 
Strengths and weaknesses  212 
The study followed a prospectively registered protocol, using detailed methodology, large patient 213 
populations and up to date statistical techniques for the meta-analysis (22, 23).  We demonstrated 214 
both the prognostic association of ultrasound markers with adverse outcome (odds ratio) and their 215 
predictive ability (positive predictive value). 216 
The small studies and smaller number of studies for a certain ultrasound marker may be associated 217 
with more uncertain results. This is somewhat adjusted for by the meta-analysis process and the 218 
resultant 95% confidence intervals of the odds ratios. 219 
A comparison of the accuracy of different tests using studies that did not compare the tests within the 220 
same study population could be prone to confounding. Only four of the included studies compared 221 
multiple measures of suspected fetal macrosomia (EFW, AC, AD-BPD, and HC) within the same 222 
population. All four of these studies recorded outcome data for shoulder dystocia and just one of 223 
these studies recorded outcome data for BPI. In the case of the outcome shoulder dystocia, the 224 
individual study results proved consistent with the meta-analysis findings that used all of the available 225 
studies to compare the multiple tests, suggesting reliability.  For the outcome of BPI there were 226 
significantly less studies and therefore no meta-analysis was possible. The individual study results 227 
compared different populations and thus the results we have presented for BPI are at a higher risk of 228 
confounding. 229 
One weakness of the study is that the data on CS did not differentiate between elective and 230 
emergency CS and therefore did not account for ‘treatment paradox’. 231 
Comparison to other studies 232 
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Previous studies have focused on the diagnostic accuracy of antenatal prediction of fetal macrosomia 233 
in comparison to absolute birth weights.  Currently there are no studies that have systematically 234 
reviewed our index tests in relation to delivery and neonatal outcomes. A Cochrane review published 235 
in 2016 (24) asked a similar question. Culliney et al, focused on the benefits and harms associated with 236 
different combinations of surveillance methods for the suspected LGA fetus but they found no RCTs 237 
that assessed the effect of the antenatal fetal surveillance regimens on important health outcomes 238 
for the mother and baby. The absence of randomised controlled trials revealed an area where 239 
research is needed. Our study relied on observational data in the form of cohort and case-control 240 
studies. Observational data is prone to bias.   In the absence of RCT data, systematic review and meta-241 
analysis of the observational trials became the best option to get data on this question.   242 
This is the first study to our knowledge to examine which antenatal imaging measures of fetal 243 
macrosomia best predict adverse maternal and neonatal outcomes. No other review has attempted 244 
to compare different definitions of suspected fetal macrosomia to inform clinical practice.  This is more 245 
useful information for clinicians needing to counsel women with suspected fetal macrosomia. 246 
CONCLUSION 247 
Estimated fetal weight is the most widely used ultrasound marker to predict fetal macrosomia in the 248 
UK. However, this study suggests that other markers have a higher positive predictive value for 249 
adverse outcomes associated with fetal macrosomia. 250 
When counselling women with suspected fetal macrosomia and offering interventions to reduce 251 
shoulder dystocia, clinicians should be aware that this research would suggest that ultrasound markers 252 
which look at the difference between the size of the fetal abdomen and head or the size of the fetal 253 
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